Latest Breaking News On - Balaxi pharmaceuticals - Page 1 : comparemela.com

Hyderabad (Telangana) [India], December 13 (ANI/NewsVoir): NSE listed Balaxi Pharmaceuticals Limited, a leading IPR branded pharmaceutical company, performed the groundbreaking ceremony of its US-FDA, EU-GMP, WHO-Geneva Compliant Pharmaceutical Formulation Plant at Jadcherla Mandal, Telangana. The company will be investing Rs. 85 crores in the state-of-the-art facility over a period of one year that will enable them to enter European markets as well as enhance margins in current markets. To drive this initiative forward, a leading consultant, Spectrum Pharmatech Consultant Private Limited has been appointed for the smooth and time bound project execution. Spectrum Pharmatech Pvt. Ltd., Mumbai is the Design, Engineering, and Turnkey Execution Consultant for this project. The plant will provide direct and indirect employment to approximately 350+ individuals. This US-FDA, EU-GMP, WHO-Geneva Compliant Pharmaceutical Formulation facility is housed across approximately 1,50,000 square feet,

Dominican republicEl salvadorAndhra pradeshJadcherla mandalBalaxi pharmaAashish maheshwariBalaxi pharmaceuticals ltdBalaxi pharmaceuticalsSpectrum pharmatech consultant privateBalaxi pharmaceuticals limitedGeneva compliant pharmaceutical formulation plantSpectrum pharmatech consultant private limitedTurnkey execution consultantGeneva compliant pharmaceutical formulationManaging directorSpectrum pharma consultants